Found 148 matching trials
Mathematical Modeling to Predict Response to Neoadjuvant Chemotherapy in Breast Cancer
N/AThis is a feasibility study evaluating the use of a mathematical model to p...
Location
University of New Mexico Comprehensive Cancer Center
Low-dose Apatinib Combined With Neoadjuvant Chemotherapy in the Treatment of Early Triple Negative Breast Cancer
PHASE2Triple-negative breast cancer (TNBC) is a special type of breast cancer, en...
Location
Guangdong general hospital
Trial of Neoadjuvant Docetaxel ± Metronomic Capecitabine/CTX Followed by FEC in Women With Operable Triple Negative Breast Cancer
PHASE2This multi-center, open-label, phase II randomized controlled trial is to e...
Location
Sun Yat-sen Memorial Hospital
Study of Neoadjuvant Endocrine Therapy in HR Positive and HER2 Negative Premenopausal Breast Cancer Patients
PHASE2A multicenter, prospective, open, randomized cohort, non controlled phase I...
A Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy in Untreated Metastatic Breast Cancer (RIBBON 1)
PHASE3This is a Phase III, multicenter, randomized, placebo-controlled trial desi...
Location
Multiple Locations
Neoadjuvant Treatment of Breast Cancer
N/AObservational investigation of participants who are given neoadjuvant treat...
Location
National Institute of Oncolgy
Efficacy and Safety of Neoadjuvant DC-T in Breast Cancer Patients
PHASE4This is a multicentric, open-label,non-randomized concurrent control, 1:1 m...
Neoadjuvant Response-guided Treatment of HER2 Positive Breast Cancer
PHASE2The purpose of this trial is to evaluate efficacy and toxicity of either th...
Status
Active Not Recruiting
Location
Dept. of Oncology, Ărebro University Hospital
Epirubicin Versus Docetaxel Plus Cyclophosphamide in Lymph Node Negative, ER-positive, Her2-negative Breast Cancer
PHASE4The purpose of this study is to compare the safety and efficacy of epirubic...
Neoadjuvant and Adjuvant Ribociclib and ET for Clinically High-risk ER+ and HER2- Breast Cancer
PHASE2This is an open-label, multicenter international trial in men and women wit...
Status
Active Not Recruiting
Location
Sainte Catherine - Institut du Cancer Avignon Provence